Draft:Lynda Stuart
American scientist
From Wikipedia, the free encyclopedia
Lynda Maria Stuart is a Jamaican physician-scientist and the President and Chief Executive Officer of Fund for Science and Technology (FFST). Before leading FFST, she was the Executive Director of the Institute for Protein Design at the University of Washington. She is best known for her leadership roles in immunology and global health.[1][2][3]
 | This is a draft article. It is a work in progress open to editing by anyone. Please ensure core content policies are met before publishing it as a live Wikipedia article. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Last edited by Wasianpower (talk | contribs) 5 months ago. (Update)
Finished drafting? |
Lynda Stuart | |
|---|---|
| Alma mater | University of Edinburgh, University of Cambridge, University of London |
| Scientific career | |
| Fields | Biology |
| Institutions | University of Washington |
| Doctoral advisor | John Savill, Adam Lacy-Hulbert |
Education and Career
Stuart earned her Bachelor's in Arts in Medical Science/Social and Political Science from Cambridge University and her MBBS from the University of London. She earned her PhD. in immunology at the University of Edinburgh under the guidance of John Savill and Adam Lacy-Hulbert. She trained as a postdoctoral scholar with Alan Ezekowitz at Massachusetts General Hospital.[4][5]
After her postdoctoral training, Stuart was a faculty member of the Massachusetts General Hospital and Harvard Medical School. From 2016 to 2022, Stuart was the Deputy Director at the Bill & Melinda Gates Foundation and was involved with the development of Skycovione with the Institute for Protein Design. She was the Vice President of Infectious Disease at the mRNA company BioNTech.
